Materials science for medical and drug-delivery products
Hydrogels, polymers and biomaterials can change after sterilization, aging or scale-up. Our edge is polymer and radiation science applied to device, drug-delivery and wound-care products.
What we do
What we prepare for materials-driven product teams
Each item links to a service page with deliverables, inputs and boundaries. We prepare technical evidence, plans and strategy. We do not certify products, approve submissions or give legal opinions.
Radiation sterilization
Material compatibility with gamma and electron-beam sterilization, dose-setting strategy under ISO 11137, aging plans and support for moving away from ethylene oxide.
Radiation sterilizationHydrogel and polymer formulation
Hydrogel and polymer systems for topical, injectable and wound-care products, including radiation crosslinking, gel fraction, swelling and release.
Formulation developmentCharacterization and E&L
Method plans for characterization, and extractables and leachables study plans under ISO 10993-18.
Assay developmentBiocompatibility
Risk-based biological evaluation plans under ISO 10993-1, chemical characterization and toxicological risk assessment, including material or supplier changes.
BiocompatibilityTarget product profile
Minimum and target product attributes for a new material or dressing, each mapped to a test method.
Target product profilePatent landscape
Landscapes by chemistry and use for counsel to review. Technical analysis, not a legal opinion.
Patent landscapeWe work with products for medical, drug-delivery, wound-care and cosmetic use. We do not run testing; we plan it and interpret results with your laboratory.
Illustrative situations
Problems we are typically asked to solve
These describe typical client types and problems. They are not client results, and we cannot promise outcomes, approvals or timelines.
A multi-polymer device is moving from ethylene oxide to radiation
Medical device manufacturer. A device combines several polymers. Some, such as PTFE, degrade under radiation, others need radiation-grade grades, and discoloration is a concern.
How we advise. We review each material, advise on gamma versus electron beam, outline dose mapping and dose setting, and plan post-irradiation aging tests.
You receive. A material compatibility review, ranked sterilization options and a test plan.
A hydrogel changes properties after gamma sterilization
Hydrogel product developer. Swelling and strength shift after sterilization, and the team does not know whether dose, method or formulation is the cause.
How we advise. We assess electron beam, lower doses and formulation changes, and design the experiments that separate the causes.
You receive. A cause assessment, options with trade-offs and an experiment plan.
A supplier changes a colorant
Device manufacturer. A supplier proposes a new colorant in a patient-contacting component, and the team asks whether biological testing must be repeated.
How we advise. We review the change against the risk-based approach of ISO 10993-1, with attention to chemistry, and document the reasoning.
You receive. A written rationale for your file, with test recommendations if the change warrants them.
Describe your materials project
Send a general description of the problem and your deadline. A scientist follows up by email and prepares a written quote once the scope is clear.